Solution conformation of a G.cntdot.TA [guanosine.cntdot.thymidine-5'-adenylic acid] triple in an intramolecular pyrimidine.cntdot.purine.cntdot.pyrimidine DNA triplex

1992 ◽  
Vol 114 (17) ◽  
pp. 6913-6915 ◽  
Author(s):  
Ishwar Radhakrishnan ◽  
Dinshaw J. Patel ◽  
James M. Veal ◽  
Xiaolian Gao
Biochemistry ◽  
1997 ◽  
Vol 36 (47) ◽  
pp. 14502-14511 ◽  
Author(s):  
John P. Bartley ◽  
Tom Brown ◽  
Andrew N. Lane

2020 ◽  
Vol 20 (16) ◽  
pp. 1943-1955
Author(s):  
Neelam Lohani ◽  
Moganty R. Rajeswari

Background: The high mobility group box 1 (hmgb1) is one of the frequently over-expressed genes whose aberrant expression is reported in a number of human cancers. Various strategies are underway to inhibit hmgb1 expression in cancer cells having considerable therapeutic value. Objective: The present work involves selective transcriptional inhibition of the hmgb1 gene using selective DNA triplex structure-based gene technology. Here, the promoter region of the hmgb1 gene at position (-183 to -165) from the transcription start site as a target was selected using bioinformatic tools. Methods: The DNA triplex formation by the DNA of the target gene and TFO was confirmed using UV absorption spectroscopy, Circular Dichroism, and Isothermal Calorimetry. Results: Treatment of HepG2 cell with specific Triplex-forming Oligonucleotide significantly downregulated HMGB1 expression level at mRNA and protein levels by 50%, while the classical anticancer drugs, actinomycin/ adriamycin as positive controls showed 65% and the combination of TFO and drug decreased by 70%. The anti-proliferative effects of TFO correlated well with the fact of accumulation of cells in the Go phase and apoptotic cell death. Further, the binding of anti-cancer drugs to hmgb1 is stronger in DNA triplex state as compared to hmgb1 alone, suggesting the combination therapy as a better option. Conclusion: Therefore, the ability of hmgb1 targeted triplex-forming oligonucleotide in combination with triplex selective anticancer drug holds promise in the treatment of malignancies associated with hmgb1 overexpression. The result obtained may open up new vistas to provide a basis for the rational drug design and searching for high-affinity ligands with a high triplex selectivity.


1987 ◽  
Vol 52 (11) ◽  
pp. 2810-2818 ◽  
Author(s):  
Emil Paleček ◽  
František Jelen ◽  
Vladimír Vetterl

The behaviour of electrochemically reducible single-strand polynucleotides (poly(adenylic acid)) and poly(cytidylic acid)) was studied by the differential (derivative) pulse polarography (DPP) and by other methods. Measurements were performed with the help of the dropping mercury electrode under various conditions specified by the pulse width, pulse amplitude, drop time etc. For the faradaic and tensammetric DPP peaks the diagnostic criteria were proposed which make it possible to classify even very small DPP peaks of double helical polynucleotides.


1973 ◽  
Vol 248 (23) ◽  
pp. 8207-8215
Author(s):  
K.W. Rabinowitz ◽  
R.A. Niederman ◽  
W.A. Wood

1957 ◽  
Vol 227 (2) ◽  
pp. 999-1007 ◽  
Author(s):  
Ya-Pin Lee
Keyword(s):  

1957 ◽  
Vol 224 (2) ◽  
pp. 899-908 ◽  
Author(s):  
N.B. Madsen ◽  
Carl F. Cori

Sign in / Sign up

Export Citation Format

Share Document